Main Menu

Cancer Biomarkers Team

Professor Johann de Bono’s team conducts biomarker-driven clinical and translational research to accelerate the development of novel cancer therapies and improve understanding of cancer biology, drug sensitivity and resistance.

Team leader

Professor Johann de Bono

Professor Johann de Bono

Regius Professor of Cancer Research

Professor Johann de Bono is Head of the Division of Clinical Studies and an international expert in the development of molecularly targeted cancer therapies against adult cancers. He runs one of the world’s largest phase I clinical trials units for cancer and has also led phase III trials of the prostate cancer drugs abiraterone and cabazitaxel.

ORCID 0000-0002-2034-595X

Team members

Zai Ahmad

Senior Scientific Officer

Mark Atkin

Scientific Officer

Claudia Bertan

Scientific Officer

Gunther Boysen

Postdoctoral Fellow

Suzanne Carreira

Staff Scientist

Rossitza Christova

Higher Scientific Officer

Andreas Chrysostomou

Scientific Officer

Matthew Clarke

Bioinformatics Officer

Mateus Crespo

Higher Scientific Officer

Flavia Mendes de Oliveira

Scientific Officer

David Dolling

Statistician

Bernadette Ebbs

Higher Scientific Officer

Ana Ferreira

Scientific Officer

Ines Figueiredo

Higher Scientific Officer

Penny Flohr

Senior Scientific Officer

Gemma Fowler

Scientific Officer

Veronica Gil

Higher Scientific Officer

Jane Goodall

Higher Scientific Officer

Maryou Lambros

Senior Scientific Officer

Claire Midgley

Admin Assistant

Susana Miranda

Higher Scientific Officer

Antje Neeb

Senior Scientific Officer

Rita Pereira

Scientific Officer

Lorna Pope

Higher Scientific Officer

Helder Ramos

Data Manager

Ruth Riisnaes

Senior Scientific Officer

Daniel Nava Rodrigues

Pathologist / PhD student

George Seed

PhD student

Adam Sharp

Clinical Research Fellow

Semini Sumanasuriya

Clinical Research Fellow/PhD Student

Jon Welti

Senior Scientific Officer

Wei Yuan

Senior Bioinformatics Officer